310 related articles for article (PubMed ID: 15919445)
21. Pharmacokinetic study of the combination of tacrolimus and fluconazole in renal transplant patients.
Lumlertgul D; Noppakun K; Rojanasthien N; Kanchanarattanakorn K; Jittikanont S; Manoyot A; Bunnachak D; Ophascharoensuk V
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S73-8. PubMed ID: 17044457
[TBL] [Abstract][Full Text] [Related]
22. Higher intracerebral concentration of tacrolimus after intermittent than continuous administration to rats.
Sakamoto Y; Makuuchi M; Harihara Y; Imamura H; Sato H
Liver Transpl; 2001 Dec; 7(12):1071-6. PubMed ID: 11753909
[TBL] [Abstract][Full Text] [Related]
23. Switching monitoring of emulsified cyclosporine from trough level to 2-hour level in stable liver transplant patients.
Langers P; Cremers SC; den Hartigh J; Veenendaal RA; ten Hove WR; Ringers J; Lamers CB; van Hoek B
Liver Transpl; 2004 Feb; 10(2):183-9. PubMed ID: 14762854
[TBL] [Abstract][Full Text] [Related]
24. Optimizing tacrolimus therapy in the maintenance of renal allografts: 12-month results.
Bolin P; Shihab FS; Mulloy L; Henning AK; Gao J; Bartucci M; Holman J; First MR;
Transplantation; 2008 Jul; 86(1):88-95. PubMed ID: 18622283
[TBL] [Abstract][Full Text] [Related]
25. Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant.
Pawinski T; Durlik M; Szlaska I; Urbanowicz A; Majchrnak J; Gralak B
J Clin Pharm Ther; 2006 Feb; 31(1):27-34. PubMed ID: 16476117
[TBL] [Abstract][Full Text] [Related]
26. Interindividual variation of maximal blood levels of tacrolimus after its oral administration in hematopoietic cell transplant recipients.
Yamazaki R; Mori T; Aisa Y; Kato J; Nakamura Y; Nakazato T; Mihara A; Ikeda Y; Okamoto S
Transplant Proc; 2009 Jun; 41(5):1831-3. PubMed ID: 19545738
[TBL] [Abstract][Full Text] [Related]
27. Cyclosporine trough levels in renal graft recipients.
Jauhari H; Wadhawan S; Yashpal ; Kumar A
J Indian Med Assoc; 1999 Nov; 97(11):476-7. PubMed ID: 10638120
[TBL] [Abstract][Full Text] [Related]
28. Effects of Miconazole Oral Gel on Blood Concentrations of Tacrolimus and Cyclosporine: A Retrospective Observational Study.
Ishiwata Y; Nagata M; Arai T; Makiishi M; Yoshikawa M; Takahashi H; Kohsaka H; Yasuhara M
Ther Drug Monit; 2016 Dec; 38(6):717-721. PubMed ID: 27559841
[TBL] [Abstract][Full Text] [Related]
29. Comparison of cyclosporine concentrations 2 hours post-dose determined using 3 different methods and trough level in pediatric renal transplantation.
Rodríguez E; Delucchi MA; Cano F; Valdebenito S; Castillo MC; Villegas R
Transplant Proc; 2005 Oct; 37(8):3354-7. PubMed ID: 16298594
[TBL] [Abstract][Full Text] [Related]
30. Clinical application of monitoring mycophenolic acid trough concentration in heart transplant recipients--single center's experience.
Zakliczyński M; Szewczyk M; Zakliczyńska H; Zembala M
Ann Transplant; 2005; 10(2):38-45. PubMed ID: 16218032
[TBL] [Abstract][Full Text] [Related]
31. Optimal initial dose of orally administered once-daily extended-release tacrolimus following intravenous tacrolimus therapy after liver transplantation.
Mita A; Ikegami T; Masuda Y; Katsuyama Y; Ohno Y; Urata K; Nakazawa Y; Kobayashi A; Miyagawa S
Transplant Proc; 2014 Apr; 46(3):794-6. PubMed ID: 24767351
[TBL] [Abstract][Full Text] [Related]
32. A prospective cross-over study comparing the pharmacokinetics of cyclosporine A and its metabolites after oral versus short-time intravenous cyclosporine A administration in pre-heart transplant patients.
Lehle K; Kirchner GI; Rupprecht L; Gruber M; Birnbaum DE; Schmid FX; Preuner JG
Transplant Proc; 2007 Dec; 39(10):3323-8. PubMed ID: 18089380
[TBL] [Abstract][Full Text] [Related]
33. Severe elevations of FK506 blood concentration due to diarrhea in renal transplant recipients.
Sato K; Amada N; Sato T; Miura S; Ohashi Y; Sekiguchi S; Satomi S; Okazaki H
Clin Transplant; 2004 Oct; 18(5):585-90. PubMed ID: 15344965
[TBL] [Abstract][Full Text] [Related]
34. Prediction of intravenous cyclosporine area under the concentration-time curve after allogeneic stem cell transplantation.
Duncan N; Arrazi J; Nagra S; Cook M; Thomson AH; Craddock C
Ther Drug Monit; 2010 Jun; 32(3):353-8. PubMed ID: 20224513
[TBL] [Abstract][Full Text] [Related]
35. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
[TBL] [Abstract][Full Text] [Related]
36. Conversion from tacrolimus to cyclosporine microemulsion therapy in liver transplant recipients.
Ogino S; Hashikura Y; Katsuyama Y; Ikegami T; Nakazawa Y; Urata K; Terada M; Miyagawa S; Kawasaki S
Transplant Proc; 2004 Mar; 36(2 Suppl):299S-301S. PubMed ID: 15041357
[TBL] [Abstract][Full Text] [Related]
37. Effect of plasma lipid on pharmacokinetics of ciclosporin and its relationship with plasma prednisolone level in renal transplant patients.
Sugioka N; Kokuhu T; Okamoto M; Yoshimura N; Ito Y; Shibata N; Takada K
J Pharm Pharmacol; 2006 Sep; 58(9):1193-200. PubMed ID: 16945177
[TBL] [Abstract][Full Text] [Related]
38. Oseltamivir, an influenza neuraminidase inhibitor drug, does not affect the steady-state pharmacokinetic characteristics of cyclosporine, mycophenolate, or tacrolimus in adult renal transplant patients.
Lam H; Jeffery J; Sitar DS; Aoki FY
Ther Drug Monit; 2011 Dec; 33(6):699-704. PubMed ID: 22105586
[TBL] [Abstract][Full Text] [Related]
39. Pharmacodynamic analysis of tacrolimus and cyclosporine in living-donor liver transplant patients.
Fukudo M; Yano I; Masuda S; Fukatsu S; Katsura T; Ogura Y; Oike F; Takada Y; Tanaka K; Inui K
Clin Pharmacol Ther; 2005 Aug; 78(2):168-81. PubMed ID: 16084851
[TBL] [Abstract][Full Text] [Related]
40. Time-dependent changes in cyclosporine exposure: implications for achieving target concentrations.
Felipe CR; Silva HT; Machado PG; Garcia R; Moreira SR; Pestana JO
Transpl Int; 2003 Jul; 16(7):494-503. PubMed ID: 12677364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]